Lunai Bioworks Inc. (RENB)
NASDAQ: RENB
· Real-Time Price · USD
1.42
0.00 (0.00%)
At close: Jun 09, 2025, 3:59 PM
Lunai Bioworks Ratios and Metrics
Financials in USD. Fiscal
year is
July - June.
Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
PE Ratio | 116.53 | -4.66 | -0.43 | -2.39 | -4.73 | -11.52 | -7.85 | -0.39 | -2.96 | -3.21 | -3.24 | -0.28 | -17.51 | -14.49 | -8.44 |
PEG Ratio | -1.13 | 0.06 | -0.01 | n/a | -0.04 | 0.23 | 0.13 | -0.00 | 0.79 | 0.08 | 0.04 | -0.00 | 2.28 | 0.41 | 0.18 |
PS Ratio | n/a | n/a | n/a | 827.47 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.00 | 1.65 | 0.77 | 1.14 | 1.91 | 4.79 | 6.17 | 0.78 | 0.77 | 0.85 | 1.42 | 1.41 | 2.69 | 2.30 | 2.10 |
P/FCF Ratio | 0.00 | -52.82 | -37.53 | -61.6 | -122.18 | -65.48 | -103.78 | -15.93 | -15.48 | -16.77 | -37.58K | -33.54 | -155.95 | -82.55 | -66.54 |
P/OCF Ratio | 0.00 | -52.82 | -37.53 | -62.2 | -122.42 | -66.34 | -103.78 | -15.97 | -15.48 | -16.89 | -37.58K | -33.54 | -155.95 | -82.55 | -66.6 |
OCF/S Ratio | n/a | n/a | n/a | -13.3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.08 | 0.08 | 0.04 | 0.03 | 0.05 | 0.17 | 0.10 | 0.12 | 0.11 | 0.10 | 0.10 | 0.10 | 0.05 | 0.04 | 0.04 |
Quick Ratio | 0.13 | 0.06 | 0.08 | 0.07 | 0.06 | 0.17 | 0.19 | 0.23 | 0.33 | 6.16 | 1.14 | 1.48 | 1.56 | 2.36 | 12.77 |
Current Ratio | 0.13 | 0.06 | 0.08 | 0.07 | 0.06 | 0.17 | 0.19 | 0.23 | 0.33 | 6.16 | 1.14 | 1.48 | 1.56 | 2.36 | 12.77 |
Asset Turnover | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -22.07 | -39.17 | -213.29 | -65.46 | -53.71 | -15.53 | -49.56 | -87.45 | -15.34 | -47.02 | -75.23 | -52.44 | -42.38 | -67.79 | -83.63 |
Return on Equity | n/a | -0.09 | -0.45 | -0.12 | -0.1 | -0.1 | -0.2 | -0.5 | -0.07 | -0.07 | -0.11 | -1.24 | -0.04 | -0.04 | -0.06 |
Return on Assets | n/a | -0.07 | -0.36 | -0.1 | -0.08 | -0.08 | -0.16 | -0.4 | -0.05 | -0.06 | -0.09 | -1.07 | -0.03 | -0.04 | -0.06 |
Return on Invested Capital | -0.04 | -0.05 | -0.52 | -0.13 | -0.09 | -0.08 | -0.17 | -0.44 | -0.06 | -0.05 | -0.09 | -0.06 | -0.02 | -0.03 | -0.04 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | 0.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | -86.7 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | -86.7 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | -94.26 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | -13.43 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | -287.63 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |